3Kalousova M, Zima T, Tesar V, et al. Relationship between ad- vanced glycoxidation end products, inflammatory markers/acute- phase reactants, and some autoantibodies in chronic hemodialysis patients[J].Kidney Int Suppl, 2003,84 (Suppl) : S62-64.
4Stenvinkel P, Heimburger O, Tuck C, et al. Apo (a) -isoform size, nutritional status and inflammatory markers in chronic renal failure [J]. Kidney Int,1998, 53(5):1336-1342.
5Stenvinkel P, Heimburger O, Pauhre F, et al. Strong association between malnutrition, inflammation and atherosclerosis in chronic renal failure[J]. Kidney Int, 1999, 55(5): 1899-1911.
6Zethelius B, Berglund L, Sundstrom J, et al. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes[J]. N Engl J Med, 2008, 358(20):2107-2116.
7Parekh RS, Plantinga LC, Kao WH, et al. The association of sudden cardiac death with inflammation and other traditional risk factors[J]. Kidney Int, 2008, 74(10): 1335-1342.
二级参考文献21
1OLSEN M H, HJERKINN E, WACHTELL K, et al. Are left ventricular mass, geometry and function related to vascular changes and/or insulin resistance in long-standing hypertension [ J ]'? J Hum Hypertens, 2003 , 17 (5) : 305-311.
2MULLER C, REDDERT A, WASSMANN S, et al. Insulin like growth factor induces up-regulation of AT ( 1 ) .-receptor gene expression in vascular smooth muscle cells [ J]. J Rinin Angiotensin Aldosterone Syst, 2000, 1 (3) : 273-277.
3TIAN H, MA A, LI C, et al. Correlative factors of insulin resistance in essential hypertension [J]. Hypertens Res, 2000, 23( 3 ) : 265-270.
4FRYSTYK J, LEDET T, MOLLER N. Cardiovascular disease and insulin-like growth factor-I [J]. Circulation, 2002, 106 (8) :893 -895.
5VON-LEWINSKI D, VOSS K, HULSMANN S, et al. Insulin-like growth factor-1 exerts Ca^2+ -dependent positive in otropic effects in r ]failing human myocardium[J].Circ Res, 2003, 92 (2) : 169-176.
6PAULIKS L B, COLE E K, MERGNER W J. Increased insulinlike growth factor-1 protein in human left ventricular hypertrophy[J]. Exp Mol Pathol, 1999, 66 (1) : 53-58.
7STAWOWY P, KALLISCH H, KILIMNIK A, et al. Proprotein convertases regulate insulin-like growth factor 1-induced membrane-type 1 matrix metalloproteinase in VSMCs via endoproteolytic activation of the insulin-like growth factor-1 receptor [J]. Biochem Biophys Res Commun, 2004, 32l (3) : 531-538.
8KAMIDE K, HORI M T, ZHU J H, et al. Insulin and insulinlike growth factor-1 protnotes angiotensinogen production and growth in vascular smooth muscle cells [J]. J Hypertens, 2000,18 (8): 1051-1056.
9Kaysen GA. The microinflammatory state in uremia: causes and potential consequences[J] .J Am Sac Nephrol,2001,12(7) : 1549-1557.
10Gabay C, Kushner I. Acute-phase protein and other systemic responses to inflammation[J]. N Engl J Med, 1999,340(6) :448-454.
4Cachofeiro V,Goicochea M,de Vinuesa S G. Oxidative stress and inflammation,a link between chronic kidney disease and cardiovascular disease[J].Kidney International Supplement,2008,(S 111):S4-S9.
5Merino A,Nogueras S,Buendía P. Microinflammation and endothelial damage in hemodialysis[J].Contributions to Nephrology,2008.83-88.
7Cockcroft D W,Gault M H. Prediction of creatinine clearance from serum creatinine[J].Nephron,1976,(01):31-41.doi:10.1159/000180580.
8Schmig M,Eisenhardt A,Ritz E. The microinflammatory state of uremia[J].Blood Purification,2000,(04):327-332.
9Ramirez R,Martin Malo A,Aljama P. Inflammation and hemodiafiltration[J].Contributions to Nephrology,2007.210-215.
10Ortega O,Rodriguez I,Gallar P. Significance of high C-reactive protein levels in pre-dialysis patients[J].Nephrology Dialysis Transplantation,2002,(06):1105-1109.
